Stay updated on Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page's revision label shows v3.6.5, replacing v3.6.4. This indicates a small metadata update to the page revision history without changing the study content.
    Difference
    0.0%
    Check dated 2026-08-09T08:18:27.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    A new revision tag, v3.6.4, has been added to replace the previous v3.6.3, signaling a minor site deployment update rather than changes to the study information.
    Difference
    0.0%
    Check dated 2026-07-25T17:56:58.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.6.2 to v3.6.3, reflecting a new page revision.
    Difference
    0.0%
    Check dated 2026-07-04T13:26:45.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Version bump from v3.6.0 to v3.6.2 indicates a new platform release. It likely includes internal fixes or refinements and does not imply changes to study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-06-27T07:37:48.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Enrollment is now closed with a note that participants are no longer being sought. The page's navigation and headings were updated (e.g., addition of 'How to Read a Study Record', 'Common Questions', 'How to Join a Study', and the formatting change from 'Intervention / Treatment' to 'Intervention/Treatment'), along with a page revision tag 'Revision: v3.6.0'.
    Difference
    0.4%
    Check dated 2026-06-13T00:27:35.000Z thumbnail image
  9. Check
    80 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, indicating a small update to the page metadata or layout without altering study content.
    Difference
    0.0%
    Check dated 2026-06-05T21:33:39.000Z thumbnail image

Stay in the know with updates to Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page.